Inhibition of angiotensin II-induced vascular smooth muscle cell hypertrophy by different catechins

Korean Journal of Physiology and Pharmacology

Volumn 9, Issue 2, 2005, Pages 117-123

  Zheng, Ying ^a   Song, Hye Jin ^a   Yun, Seok Hee ^a   Chae, Yeon Jeong ^a   Jia, Hao ^a   Kim, Chan Hyung ^a   Ha, Tae Sun ^a   Sachinidis, Agapios ^b   Ahn, Hee Yul ^a   Davidge, Sandra T ^c  

^a Chungbuk National University College of Medicine   (South Korea)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Angiotensin II; Catechin; Hypertrophy; JNK; VSMC

Indexed keywords

ANGIOTENSIN; CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; GREEN TEA EXTRACT; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ASSAY; MUSCLE HYPERTROPHY; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TEA; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 21044444975     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ahn HY, Hadizadeh KR, Seul C, Yun YP, Vetter H, Sachinidis A. Epigallocatechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis -transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell 10: 1093-1104, 1999
2. Benelli R, Vene R, Bisacchi D, Garbisa S, Albini A. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem 383: 101-105, 2002
3. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle. Circ Res 80: 607-616, 1997
4. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured smooth muscle cells. Hypertension 13: 305-314, 1989
5. Black MJ, Adams MA, Bobik A, Campbell JH, Campbell GR. Vascular smooth muscle polyploidy in the development and regression of hypertension. Clin Exp Pharmacol Physiol 15: 345-348, 1988
6. 411 in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal- regulated kinase and Akt. J Biol Chem 274: 36843-36851, 1999
7. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749-756, 1988
8. Giasson E, Meloche S. Role of P70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J Biol Chem 270: 5225-5231, 1995
9. Gille H, Sharrocks A, Shaw P. Phosphorylation of p62TCF by MAP kinases stimulates ternary complex formation at c-Fos promoter. Nature 358: 414-417, 1992
10. Hixon ML, Muro-Cacho C, Wagner MW, Obejero-Paz C, Mille E, Fujio Y, Kureishi Y, Hassold T. Walsh K, Gualberto A. Akt/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J Clin Invest 106: 1011-1020, 2000
11. Hwang KC, Lee KH, Jang Y, Yun YP, Chung KH. Epigallocatechin-3-gallate inhibits basic fibroblast growth factor- induced intracellular signaling transduction pathway in rat aortic smooth muscle cells. J Cardiovasc Pharmacol 39: 271-277, 2002
12. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. Br Med J 310: 693-696, 1995
13. Kallunki T, Deng T, Hibi M, Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87: 929-939, 1996
14. Kang WS, Chung KH, Chung JH, Lee JY, Park JB, Zhang YH, Yoo HS, Yun YP. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovascular Pharmacol 38: 875-884, 2001
15. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486, 1995
16. McKay S, de Jongste JC, Saxena PR, Sharma HS. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. Am J Respir Cell Mol Biol 18: 823-833, 1998
17. Middleton Jr E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751, 2000
18. Musti AM, Treier M, Bohmann D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275: 400-402, 1997
19. Nagai K, Jiang MH, Hada J, Nagata T, Yajima Y, Yamamoto S, Nishizaki T. (-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant. Brain Res 956: 319-322, 2002
20. Nakagawa T, Yokozawa T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol 40: 1745-1750, 2002
21. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res 51: 280-289, 1982
22. Owens GK, Schwartz SM. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res 53: 491-501, 1983
23. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 67-674, 1991
24. Rivera VM, Greenberg ME. Growth factor-induced gene expression: the ups and downs of c-fos regulation. New Biol 2: 751-758, 1990
25. Sachinids A, Skach RA, Seul C, Ko Y, Hescheler J, Ahn HY, Fingerle J. Inhibition of the PDGF -receptor tyrosine phosohorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J 16: 893-895, 2002
26. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322: 339-346, 1995
27. Santana-Rios G, Orner GA, Amantana A, Provost C, Wu SY, Dashwood RH. Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat Res 495: 61-74, 2001
28. Servant MJ, Giasson E, Meloche S. Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem 271: 16047-16052, 1996
29. Smeal T, Hibi M, Kanin M. Altering the specificity of signal transduction cascades:positive regulation of c-Jun transcriptional activity by protein kinase A. EMBO 3: 6006-6010, 1994
30. Takahashi T, Kawahara Y, Okuda M, Ueno H, Takeshita A, Yokoyama M. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem 272: 16018-16022, 1997
31. Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y, Yokoyama M. Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cell. Am J Physiol 276: H1927-H1934, 1999
32. Takeuchi K, Nakamura N, Cook NS, Pratt RE, Dzau VJ. Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway. Biochem Biophys Res Commun 172: 1189-1194, 1990
33. Tijburg LB, Mattern T, Folts JD, Weisgerber UM, Katan MB. Tea flavonoids and cardiovascular diseases. Crit Rev Food Sci 37: 771-785, 1997
34. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998
35. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase by angiotensin II in vascular smooth muscle cells. J Bio Che 274: 22699-22704, 1999
36. Weber AA, Neuhaus T, Skach RA, Hescheler J, Ahn HY, Schror K, Ko Y, Sachinidis A. Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB J 18: 128-130, 2004
37. Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type I (HIV-1). Antiviral Res 53: 19-34, 2002
38. Yamane T, Takahashi T, Kuwata K, Oya K, Inagake M, Kitao Y, Suganuma M, Fujiki H. Inhibition of N-methyl-N′-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55: 2081-2084, 1995
39. Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamaki T. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol 60: 656-665, 2001
40. Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon JH, Terao J, Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun 293: 1458-1465, 2002
41. Zheng Y, Song HJ, Kim CH, Kim HS, Kim EG, Sachinidis A, Ahn HY. Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II. J Cardiovasc Pharmacol 43: 200-208, 2004